GlaxoSmithKline (GSK) was downgraded to a Hold Rating at Jefferies
In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
GSK Steps Up Parkinson’s Focus With US Biotech Deal
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GSK Vaccines’ shingles ad campaign warns about the year-round threat
The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.
PharmiWeb2d
ViiV Healthcare deepens its commitment to under-served LGBTI communities, pledging $7.8million in new funding
ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with ...
The Lancet2d
It is time for World Hepatitis Testing Week
5 Integrating testing for other infectious diseases, such as HIV, tuberculosis, and sexually transmitted infections, and non-communicable diseases, such as diabetes and hypertension, is essential.
ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Business Insider6d
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. Read More on GB:GSK: GSK NewsMORE Related Stocks Indices ...
Zacks.com on MSN6d
Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook
Gilead Sciences, Inc. GILD reported better-than-expected third-quarter results and raised its annual earnings guidance.
CC Chemokine Receptor Type 5 Market Research Report 2024
The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...